Further evidence to support judicious use of antibiotics in patients with cancer.
作者信息
Luke J J, Pal S K
机构信息
University of Chicago, Chicago, USA.
City of Hope, USA.
出版信息
Ann Oncol. 2018 Jun 1;29(6):1349-1351. doi: 10.1093/annonc/mdy153.
Abstract
摘要
相似文献
1
Further evidence to support judicious use of antibiotics in patients with cancer.支持对癌症患者合理使用抗生素的进一步证据。
Ann Oncol. 2018 Jun 1;29(6):1349-1351. doi: 10.1093/annonc/mdy153.
2
Lung cancer in 2013: Refining standard practice and admitting uncertainty.2013年的肺癌：完善标准治疗方法并承认存在不确定性。
Nat Rev Clin Oncol. 2014 Feb;11(2):69-70. doi: 10.1038/nrclinonc.2013.251. Epub 2014 Jan 21.
3
Non-small cell lung cancer clinical practice guidelines in oncology.肿瘤学非小细胞肺癌临床实践指南
J Natl Compr Canc Netw. 2006 Jul;4(6):548-82. doi: 10.6004/jnccn.2006.0046.
4
The judicious use of antibiotics.抗生素的合理使用。
Indian J Pediatr. 2006 Aug;73(8):744; author reply 744. doi: 10.1007/BF02898461.
5
Eighth World Conference on Lung Cancer, Dublin, August 1997.第八届世界肺癌大会，都柏林，1997年8月
Thorax. 1998 Jan;53(1):5-6. doi: 10.1136/thx.53.1.5.
6
Contemporary non-small cell lung cancer practice in the United Kingdom.英国当代非小细胞肺癌的诊疗情况
Clin Oncol (R Coll Radiol). 2004 Aug;16(5):379-80. doi: 10.1016/j.clon.2004.04.005.
7
Impact of randomized clinical trials on clinical practice regarding treatment of lung cancer.随机临床试验对肺癌治疗临床实践的影响。
J Thorac Oncol. 2007 May;2(5):456. doi: 10.1097/01.JTO.0000268682.17991.bf.
8
Action point: intraoperative lymph node staging.行动要点：术中淋巴结分期。
Eur J Cardiothorac Surg. 2012 Apr;41(4):839-40. doi: 10.1093/ejcts/ezr061.
9
Euthanasia: from ethical debate to clinical reality.安乐死：从伦理辩论到临床现实。
Eur Respir J. 2012 Oct;40(4):804-5. doi: 10.1183/09031936.00039112.
10
Strategies for promoting judicious use of antibiotics by doctors and patients.促进医生和患者合理使用抗生素的策略。
BMJ. 1998 Sep 5;317(7159):668-71. doi: 10.1136/bmj.317.7159.668.
引用本文的文献
1
Antibiotic adoption effects on nutrition and quality of life in lung cancer patients undergoing radiotherapy and chemotherapy: A meta-analysis.抗生素的采用对放化疗肺癌患者营养和生活质量的影响：一项荟萃分析。
Technol Health Care. 2024;32(6):4515-4536. doi: 10.3233/THC-240660.
2
The East Asian gut microbiome and its role in oncology: a narrative review.东亚肠道微生物群及其在肿瘤学中的作用：一篇叙述性综述。
Singapore Med J. 2025 Aug 1;66(8):426-430. doi: 10.4103/singaporemedj.SMJ-2022-042. Epub 2023 Jun 1.
3
Mitochondria and Antibiotics: For Good or for Evil?线粒体与抗生素：是福还是祸？
Biomolecules. 2021 Jul 17;11(7):1050. doi: 10.3390/biom11071050.
4
Gut microbiota influence tumor development and Alter interactions with the human immune system.肠道微生物群影响肿瘤的发展，并改变与人类免疫系统的相互作用。
J Exp Clin Cancer Res. 2021 Jan 25;40(1):42. doi: 10.1186/s13046-021-01845-6.
5
A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives.癌症风险与治疗中的一个重要问题：抗生素是积极因素还是消极因素？当前的答案及可能的替代方案。
Antibiotics (Basel). 2020 Sep 6;9(9):580. doi: 10.3390/antibiotics9090580.
6
Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma.抗生素替加环素通过下调胰腺导管腺癌中的 CCNE2 抑制细胞增殖、迁移和侵袭。
J Cell Mol Med. 2020 Apr;24(7):4245-4260. doi: 10.1111/jcmm.15086. Epub 2020 Mar 6.
7
Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers.抗生素替加环素在癌症治疗中的生物学功能和分子机制。
Int J Mol Sci. 2019 Jul 22;20(14):3577. doi: 10.3390/ijms20143577.
本文引用的文献
1
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.抗生素对晚期肾细胞癌和非小细胞肺癌患者免疫检查点抑制剂临床疗效的负相关作用。
Ann Oncol. 2018 Jun 1;29(6):1437-1444. doi: 10.1093/annonc/mdy103.
2
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.胰腺癌微生物组通过诱导先天和适应性免疫抑制促进肿瘤发生。
Cancer Discov. 2018 Apr;8(4):403-416. doi: 10.1158/2159-8290.CD-17-1134. Epub 2018 Mar 22.
3
Cancer immunotherapy using checkpoint blockade.使用免疫检查点阻断的癌症免疫疗法。
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
4
Extensive impact of non-antibiotic drugs on human gut bacteria.非抗生素药物对人体肠道细菌的广泛影响。
Nature. 2018 Mar 29;555(7698):623-628. doi: 10.1038/nature25979. Epub 2018 Mar 19.
5
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.共生微生物群与转移性黑色素瘤患者的抗PD-1疗效相关。
Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290.
6
Human microbiome signatures of differential colorectal cancer drug metabolism.结直肠癌药物代谢差异的人类微生物组特征
NPJ Biofilms Microbiomes. 2017 Nov 1;3:27. doi: 10.1038/s41522-017-0034-1. eCollection 2017.
7
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
8
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.肠道微生物群调节黑色素瘤患者对抗PD-1免疫疗法的反应。
Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.
9
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.肿瘤内细菌在介导肿瘤对化疗药物吉西他滨耐药中的潜在作用。
Science. 2017 Sep 15;357(6356):1156-1160. doi: 10.1126/science.aah5043.
10
Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.细菌代谢影响秀丽隐杆线虫对癌症化疗药物的反应。
Cell. 2017 Apr 20;169(3):431-441.e8. doi: 10.1016/j.cell.2017.03.046.
Zotero 插件